➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Baxter
Moodys
Harvard Business School
Express Scripts

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

PYLERA Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for PYLERA
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 5
Formulation / Manufacturing:see details
Drug Prices: Drug price information for PYLERA
What excipients (inactive ingredients) are in PYLERA?PYLERA excipients list
DailyMed Link:PYLERA at DailyMed
Drug patent expirations by year for PYLERA
Drug Prices for PYLERA

See drug prices for PYLERA

Recent Clinical Trials for PYLERA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Università degli Studi di SassariN/A
American University of Beirut Medical CenterPhase 4
The University of Texas Health Science Center, HoustonPhase 4

See all PYLERA clinical trials

Pharmacology for PYLERA
Drug ClassBismuth
Nitroimidazole Antimicrobial
Tetracycline-class Antimicrobial
ATC Classes for PYLERA
A01AB Antiinfectives and antiseptics for local oral treatment
A01A STOMATOLOGICAL PREPARATIONS
A01 STOMATOLOGICAL PREPARATIONS
A Alimentary tract and metabolism
A01AB Antiinfectives and antiseptics for local oral treatment
A01A STOMATOLOGICAL PREPARATIONS
A01 STOMATOLOGICAL PREPARATIONS
A Alimentary tract and metabolism
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02 DRUGS FOR ACID RELATED DISORDERS
A Alimentary tract and metabolism
D06AA Tetracycline and derivatives
D06A ANTIBIOTICS FOR TOPICAL USE
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D Dermatologicals
D06BX Other chemotherapeutics
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D Dermatologicals
G01AF Imidazole derivatives
G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G Genito-urinary system and sex hormones
J01AA Tetracyclines
J01A TETRACYCLINES
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J Antiinfectives for systemic use
J01XD Imidazole derivatives
J01X OTHER ANTIBACTERIALS
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J Antiinfectives for systemic use
P01AB Nitroimidazole derivatives
P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
P01 ANTIPROTOZOALS
P Antiparasitic products, insecticides and repellents
S01AA Antibiotics
S01A ANTIINFECTIVES
S01 OPHTHALMOLOGICALS
S Sensory organs
S02AA Antiinfectives
S02A ANTIINFECTIVES
S02 OTOLOGICALS
S Sensory organs
S03AA Antiinfectives
S03A ANTIINFECTIVES
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S Sensory organs
Paragraph IV (Patent) Challenges for PYLERA
Tradename Dosage Ingredient NDA Submissiondate
PYLERA CAPSULE;ORAL bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride 050786 2014-08-12

US Patents and Regulatory Information for PYLERA

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Get Started Free

Expired US Patents for PYLERA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006   Get Started Free   Get Started Free
Allergan PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006   Get Started Free   Get Started Free
Allergan PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2021 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
 NCE-1 Patent Challenge Dates 2021 - 2022
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group